+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

OpGen Inc (OPGN) - Financial and Strategic SWOT Analysis Review

  • ID: 4267304
  • SWOT Analysis
  • November 2021
  • 48 Pages
  • GlobalData
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • ARUP Laboratories
  • AutoGenomics Inc
  • Becton Dickinson and Co
  • bioMerieux SA
  • Cepheid Inc
  • Eurofins Genomics GmbH
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

OpGen Inc (OPGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:


  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights


OpGen Inc (OpGen) is a precision medicine company that harnesses molecular diagnostics and informatics to prevent infectious diseases caused by multi drug resistant organisms (MDROs). OpGen’s develops products that include QuickFISH, and PNA FISH products, Acuitas molecular diagnostic, and Acuitas Lighthouse informatics. OpGen offers its surveillance products and customized screening services to healthcare providers to protect the hospital biome and optimize patient care. The company sells its products in the US and abroad. OpGen is headquartered in Gaithersburg, Maryland, the US.

OpGen Inc Key Recent Developments


Nov 11, 2021: OpGen Reports Third Quarter 2021 Financial Results and Provides Business Update
Nov 04, 2021: OpGen Appoints Albert Weber as Chief Financial Officer
Oct 28, 2021: OpGen to Provide Business Update and Financial Results for the Third Quarter 2021 on November 11th at 4:30 p.m. Eastern Time
Oct 21, 2021: OpGen subsidiary Ares Genetics launches AREScloud
Oct 04, 2021: OpGen Provides Business Update and Announces Preliminary Unaudited Revenue and Cash Position for Third Quarter 2021

Key benefits of buying this profile include:


You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ARUP Laboratories
  • AutoGenomics Inc
  • Becton Dickinson and Co
  • bioMerieux SA
  • Cepheid Inc
  • Eurofins Genomics GmbH

Section 1 - About the Company

  • OpGen Inc - Key Facts
  • OpGen Inc - Key Employees
  • OpGen Inc - Key Employee Biographies
  • OpGen Inc - Major Products and Services
  • OpGen Inc - History
  • OpGen Inc - Company Statement
  • OpGen Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries

Section 2 - Company Analysis

  • Company Overview
  • OpGen Inc - Business Description
  • Product Category: Collaboration Revenue
  • Overview
  • Performance
  • Product Category: Laboratory Services
  • Overview
  • Performance
  • Product Category: Product Sales
  • Overview
  • Performance
  • R&D Overview
  • OpGen Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • OpGen Inc - Strengths
  • OpGen Inc - Weaknesses
  • OpGen Inc - Opportunities
  • OpGen Inc - Threats
  • OpGen Inc - Key Competitors

Section 3 - Company Financial Ratios

  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances

  • OpGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • OpGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • OpGen Inc, Recent Deals Summary

Section 5 - Company’s Recent Developments

  • Nov 11, 2021: OpGen Reports Third Quarter 2021 Financial Results and Provides Business Update
  • Nov 04, 2021: OpGen Appoints Albert Weber as Chief Financial Officer
  • Oct 28, 2021: OpGen to Provide Business Update and Financial Results for the Third Quarter 2021 on November 11th at 4:30 p.m. Eastern Time
  • Oct 21, 2021: OpGen subsidiary Ares Genetics launches AREScloud
  • Oct 04, 2021: OpGen Provides Business Update and Announces Preliminary Unaudited Revenue and Cash Position for Third Quarter 2021
  • Aug 12, 2021: OpGen Reports Second Quarter 2021 Financial Results and Provides Business Update
  • Aug 04, 2021: OpGen to Provide Business Update and Financial Results for the Second Quarter 2021 on August 12th at 4:30 p.m. Eastern Time
  • Aug 04, 2021: OpGen Announces the Cancellation of Adjourned Portion of Annual Meeting
  • Jul 29, 2021: OpGen: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
  • Jul 07, 2021: OpGen Announces Partial Adjournment of Annual Meeting

Section 6 - Appendix

  • Methodology
  • Ratio Definitions
  • About the Publisher

List of Tables

  • OpGen Inc, Key Facts
  • OpGen Inc, Key Employees
  • OpGen Inc, Key Employee Biographies
  • OpGen Inc, Major Products and Services
  • OpGen Inc, History
  • OpGen Inc, Subsidiaries
  • OpGen Inc, Key Competitors
  • OpGen Inc, Ratios based on current share price
  • OpGen Inc, Annual Ratios
  • OpGen Inc, Interim Ratios
  • OpGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • OpGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
  • OpGen Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios

List of Figures

  • OpGen Inc, Performance Chart (2016 - 2020)
  • OpGen Inc, Ratio Charts
  • OpGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
  • OpGen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Note: Product cover images may vary from those shown

Loading
LOADING...

A selection of companies mentioned in this report includes:

  • T2 Biosystems Inc
  • Quest Diagnostics Inc
  • Pathnostics
  • Laboratory Corp of America Holdings
  • GenMark Diagnostics Inc
  • Eurofins Genomics GmbH
  • Cepheid Inc
  • bioMerieux SA
  • Becton Dickinson and Co
  • AutoGenomics Inc
  • ARUP Laboratories
  • Accelerate Diagnostics Inc
Note: Product cover images may vary from those shown